Download PDF
Open Access
CC BY 4.0 · TH Open 2023; 07(02): e143-e154
DOI: 10.1055/a-2075-7979
Original Article

Identification of High Platelet Reactivity Despite ADP P2Y12 Inhibitor Treatment: Two Populations in the Vasodilator-Stimulated Phosphoprotein Assay and Variable PFA-P2Y Shapes of Curve

Authors

  • Cyril Mariethoz    *

    1   Faculty of Biology and Medicine, UNIL, University of Lausanne, Lausanne, Switzerland

  • Emmanuelle Scala    *

    2   Dept. of Anaesthesiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland

  • Elena Matthey-Guirao 

    3   Division of Haematology and Central Haematology Laboratory, Lausanne University Hospital (CHUV), Lausanne, Switzerland

  • Jean-Benoît Rossel 

    4   Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland

  • Francisco Javier Gomez 

    3   Division of Haematology and Central Haematology Laboratory, Lausanne University Hospital (CHUV), Lausanne, Switzerland

  • Francesco Grandoni 

    3   Division of Haematology and Central Haematology Laboratory, Lausanne University Hospital (CHUV), Lausanne, Switzerland

  • Carlo Marcucci 

    1   Faculty of Biology and Medicine, UNIL, University of Lausanne, Lausanne, Switzerland
    2   Dept. of Anaesthesiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland

  • Lorenzo Alberio 

    1   Faculty of Biology and Medicine, UNIL, University of Lausanne, Lausanne, Switzerland
    3   Division of Haematology and Central Haematology Laboratory, Lausanne University Hospital (CHUV), Lausanne, Switzerland
Further Information
Also available at
  Permissions and Reprints


Graphical Abstract

Abstract

Introduction Response to ADP P2Y12 receptor inhibition by clopidogrel can be evaluated by various techniques. Here, we compared a functional rapid point-of-care technique (PFA-P2Y) with the degree of biochemical inhibition assessed by the VASP/P2Y12 assay.

Methods Platelet response to clopidogrel was investigated in 173 patients undergoing elective intracerebral stenting (derivation cohort n = 117; validation cohort n = 56). High platelet reactivity (HPR) was defined as PFA-P2Y occlusion time <106 seconds or VASP/P2Y12 platelet reactivity index (PRI) >50%.

Results In the derivation cohort, receiver operator characteristics analysis for the ability of PFA-P2Y to detect biochemical HPR showed high specificity (98.4%) but poor sensitivity (20.0%) and a very low area under the curve (0.59). The VASP/P2Y12 assay revealed two coexisting platelet populations with different levels of vasodilator-stimulated phosphoprotein (VASP) phosphorylation: a fraction of highly phosphorylated, inhibited platelets and another of poorly phosphorylated, reactive platelets. Analysis of the PFA-P2Y curve shape revealed different types, categorized by time of occlusion (<106 seconds, 106 to 300 seconds, >300 seconds), and pattern (regular, irregular, and atypical). Noteworthy, curves with late occlusion and permeable curves with an irregular or atypical pattern correlated with VASP-PRI >50% and smaller sizes of the inhibited platelet subpopulation. Considering the PFA-P2Y shape of the curve for the detection of HPR improved sensitivity (72.7%) and preserved specificity (91.9%), with a rather high AUC (0.823). The validation cohort confirmed the VASP/P2Y12 assay data and the usefulness of considering the PFA-P2Y curve shape.

Conclusion In patients treated with acetylsalicylic acid and clopidogrel for 7-10 days, the VASP/P2Y12 assay reveals two coexisting subpopulations of differentially inhibited platelets, whose relative sizes predict global PRI and distinct PFA-P2Y curve patterns, indicating incomplete clopidogrel efficacy. The detailed analysis of both VASP/P2Y12 and PFA-P2Y is necessary for optimal detection of HPR.

Keywords

ADP P2Y12 receptor - clopidogrel - response - laboratory data - VASP

Author Contributions

Cy.M. performed research, analyzed data, and wrote the manuscript. E.S. analyzed data and edited the manuscript. E.M.G. performed research.


J.B.R. analyzed data. F.J.G. performed research.


F.G. edited the manuscript. Ca.M. analyzed data and wrote the manuscript. L.A. conceived research, analyzed data, and wrote the manuscript. All authors read and approved the submitted version of the manuscript.


* shared first authorship


Supplementary Material



Publication History

Received: 26 October 2022

Accepted: 03 April 2023

Accepted Manuscript online:
18 April 2023

Article published online:
07 June 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany